A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of PRX-00023 in Patients With Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2008
At a glance
- Drugs Naluzotan (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 19 Nov 2007 Status changed from in progress to completed.
- 26 Oct 2007 Status changed from recruiting to in progress.
- 10 Apr 2007 New trial record.